Outlook Therapeutics CEO Pankaj Mohan's 2018 pay rises 14% to $1.2M

Outlook Therapeutics reports 2018 executive compensation

By ExecPay News

Published: August 1, 2019

Outlook Therapeutics reported fiscal year 2018 executive compensation information on August 1, 2019.
In 2018, four executives at Outlook Therapeutics received on average a compensation package of $674K, a 12% decrease compared to previous year.
Average pay of disclosed executives at Outlook Therapeutics
Pankaj Mohan, Chief Executive Officer, received $1.2M in total, which increased by 14% compared to 2017.
Lawrence A. Kenyon, Chief Executive Officer, received a compensation package of $716K, which increased by 20% compared to previous year. 52% of the compensation package, or $372K, was in salary.
Kenneth M. Bahrt, Chief Medical Officer, earned $429K in 2018, a 32% decrease compared to previous year.
Stephen J. McAndrew, Former Senior Vice President, Business Strategy & Development, received $326K in 2018.
Outlook Therapeutics' fiscal year ends on September 30.

Related executives

Lawrence Kenyon

Outlook Therapeutics

Chief Financial Officer

Pankaj Mohan

Outlook Therapeutics

Chief Executive Officer

Kenneth Bahrt

Outlook Therapeutics

Chief Medical Officer

Stephen McAndrew

Outlook Therapeutics

Former Senior Vice President, Business Strategy & Development

You may also like

Source: SEC filing on August 1, 2019.